1-153374575-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_005621.2(S100A12):c.18G>A(p.Glu6Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000473 in 1,613,878 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0024 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 2 hom. )
Consequence
S100A12
NM_005621.2 synonymous
NM_005621.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.87
Genes affected
S100A12 (HGNC:10489): (S100 calcium binding protein A12) The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein is proposed to be involved in specific calcium-dependent signal transduction pathways and its regulatory effect on cytoskeletal components may modulate various neutrophil activities. The protein includes an antimicrobial peptide which has antibacterial activity. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-153374575-C-T is Benign according to our data. Variant chr1-153374575-C-T is described in ClinVar as [Benign]. Clinvar id is 770491.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.87 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00237 AC: 361AN: 152178Hom.: 4 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
361
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000725 AC: 182AN: 251192 AF XY: 0.000530 show subpopulations
GnomAD2 exomes
AF:
AC:
182
AN:
251192
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000274 AC: 401AN: 1461582Hom.: 2 Cov.: 31 AF XY: 0.000243 AC XY: 177AN XY: 727110 show subpopulations
GnomAD4 exome
AF:
AC:
401
AN:
1461582
Hom.:
Cov.:
31
AF XY:
AC XY:
177
AN XY:
727110
Gnomad4 AFR exome
AF:
AC:
277
AN:
33468
Gnomad4 AMR exome
AF:
AC:
35
AN:
44676
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26120
Gnomad4 EAS exome
AF:
AC:
0
AN:
39692
Gnomad4 SAS exome
AF:
AC:
4
AN:
86232
Gnomad4 FIN exome
AF:
AC:
4
AN:
53416
Gnomad4 NFE exome
AF:
AC:
19
AN:
1111826
Gnomad4 Remaining exome
AF:
AC:
57
AN:
60384
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00238 AC: 362AN: 152296Hom.: 4 Cov.: 32 AF XY: 0.00219 AC XY: 163AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
362
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
163
AN XY:
74466
Gnomad4 AFR
AF:
AC:
0.00803348
AN:
0.00803348
Gnomad4 AMR
AF:
AC:
0.00117586
AN:
0.00117586
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000882223
AN:
0.0000882223
Gnomad4 OTH
AF:
AC:
0.00141911
AN:
0.00141911
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 08, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at